Correction to: Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection: A structured summary of a study protocol for a randomized controlled trial

Mostrar otras versiones (1)
Detalles Bibliográficos
Autores principales: Akram, Javed, Azhar, Shehnoor, Shahzad, Muhammad, Latif, Waqas, Khan, Khalid Saeed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845337/
https://www.ncbi.nlm.nih.gov/pubmed/35168638
http://dx.doi.org/10.1186/s13063-022-06080-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845337/
https://www.ncbi.nlm.nih.gov/pubmed/35168638
http://dx.doi.org/10.1186/s13063-022-06080-8

Ejemplares similares